Artificial Intelligence (AI)

Mewburn Ellis LLP has one of Europe's leading teams of artificial intelligence patent attorneys, helping innovative companies protect and commercialise AI inventions, machine learning technologies, generative AI systems, large language models (LLMs), computer vision platforms, robotics, autonomous systems and other data-driven innovations. 

Our team includes European Patent Attorneys, UK Patent Attorneys and IP lawyers with expertise spanning AI patents, software patents, machine learning patents, deep learning inventions, neural networks, AI hardware, AI-enabled medical devices, bioinformatics, cybersecurity, fintech, quantum technologies and advanced computing. We advise start-ups, growth companies, universities and multinational businesses on patent strategy, patent drafting, European patent prosecution, freedom-to-operate, trade secrets, open-source software issues, licensing and AI intellectual property strategy, helping clients secure valuable protection for AI innovations across Europe and internationally.

Recognised for its deep expertise in software patentability and artificial intelligence patent law, Mewburn Ellis is regularly sought out by companies looking for a European patent attorney for AI, a machine learning patent expert, a software patent attorney, or strategic advice on protecting AI-enabled products. Our attorneys have extensive experience prosecuting patent applications directed to generative AI, foundation models, machine learning algorithms, explainable AI (XAI), natural language processing (NLP), computer vision, predictive analytics, digital health AI, autonomous vehicles and AI-assisted design systems. We are known for helping clients navigate complex issues surrounding AI patent eligibility, computer-implemented inventions, data-driven inventions and AI commercialisation. By combining world-class technical expertise with commercially focused intellectual property advice, Mewburn Ellis helps innovators maximise the value of their AI patents and build market-leading AI businesses

We have deep AI expertise in these sectors

webtools, E-commerce and finance

webtools, E-commerce and finance

Find out more

Health & Bio / Pharma

Health & Bio / Pharma

.

Find out more

CHEMINFORMATICS

CHEMINFORMATICS

.

Find out more

cyber security

cyber security

.

Find out more

Medtech AI

Medtech AI

.

Find out more

Transport & Logistics

Transport & Logistics

.

Find out more

Quantum AI

Quantum AI

.

Find out more

AI Hardware

AI Hardware

.

Find out more

AI assisted design and technology

AI assisted design and technology

Find out more

Agriculture

Agriculture

.

Find out more

Core AI

Core AI

.

Find out more

Mewburn Ellis AI Newsletter

Cut through the noise with Mewburn Ellis AI News - a weekly newsletter from our attorneys, decoding the latest AI developments and what they mean for your business.

 

Mewburn Ellis AI LinkedIn Newsletter

Why choose us?

  • We are a diverse and multidisciplinary team. Our powerful combination of cutting-edge technical knowledge and deep experience means clients get the right combination of skills. We build teams, picking the right people for your technical and commercial needs from across the firm. We are genuinely one team and are encouraged to work that way. It’s best for our clients.  

  • AI lives in a complex IP environment and we understand all aspects of it. We understand that open source, publications, trade secrets, patents and partnerships all have a role to play in the AI ecosystem, and we are used to helping navigate that. We work closely between our patent team and our legal team to help with issues around protection strategy, open sourcing, software licensing, and data driven collaborations.

  • We think on our feet.  Our focus is on tailoring our approach to what’s best for you. We know speed can often be key for example,  so we tailor our prosecution style accordingly. We don’t rely on letters and standard process, we call examiners, ask questions and push to shorten the prosecution timeline. Our commercial experience means we understand the pressures our clients face and act accordingly.

  • We lead the way in probing the boundaries of patent eligibility. We have been at the forefront of pushing the boundaries of what software can be patented for decades, and continue to do so in relation to AI-based technologies

  • We have a strong commercial focus. We seek to understand what our clients want to achieve, and make IP work for them. We have a wealth of experience in working closely with companies and serving as their “in-house” counsel, applying our knowledge and expertise to their commercial needs.

  • We thrive on new tech. We’re known for in working in brand new technologies right from the start and working with clients to figure out how to best to protect and leverage them.  As the forward-looking IP firm we’re passionate about progress and helping our clients maximise the potential this brings

  • We’re implementing AI in our own business. We’re excited by the potential of AI and have a strategy and action plan to implement AI into our firm.

  • We believe in the power of AI done right. As well as contributing to education on potentials and pitfalls of the technology, we are also actively looking at charities we can support in this space as part of our community programme where we donate 1% of profits to charity each year. 

Embracing AI at Mewburn Ellis

In this film, Richard Johnson, Emma Graham, Camille Terfve, Tom Furnival, Daniel Brodsky and Jane Liu share how Mewburn Ellis is embracing AI – both in the way we operate as a firm and in how we support clients at the forefront of innovation.

Drawing on expertise across bioinformatics, cheminformatics, medical technologies and photonics, they explore how AI is accelerating R&D, driving breakthroughs and creating new, complex IP challenges – and how our technical depth and strategic IP thinking helps clients protect and commercialise these advances.

Read our artificial intelligence blogs

The UKIPO's New Chapter for AI and Software Patents: A Welcome Alignment with Europe

The UKIPO's New Chapter for AI and Software Patents: A Welcome Alignment with Europe

by Emma Graham

On 14 July 2026, the UK Intellectual Property Office (UKIPO) published new statutory guidance on how patent applications will be searched and examined following the UK Supreme Court's landmark ...

AI driving Diabetes Care: Fully Closed-Loop Systems for Type 1 Diabetes Care

AI driving Diabetes Care: Fully Closed-Loop Systems for Type 1 Diabetes Care

by Susannah Dragosavac

The evolution of automated insulin delivery (AID) systems in individuals with Type 1 Diabetes (T1D) is entering a new phase. Having progressed from a pump with continuous glucose monitoring (CGM) to ...

Emotions running high - the patentability of AI considered at the UK Supreme Court

Emotions running high - the patentability of AI considered at the UK Supreme Court

by Kara Quast

On 21st and 22nd July 2025 the UK Supreme Court heard the much-anticipated case Emotional Perception AI Limited (Appellant) v Comptroller General of Patents (Respondent), which is the first time the ...

Show me the money (and the explanation): eXplainable AI in finance

Show me the money (and the explanation): eXplainable AI in finance

by Alessio Incitti

The AI assurance market in the UK is experiencing rapid growth, with an estimated 524 firms generating £1.01 billion in Gross Value Added (GVA) according to market research published in the UK ...

King’s Speech: AI implications for IP

King’s Speech: AI implications for IP

by Emma Graham

Featuring in The Patent Lawyer Magazine, Emma Graham explores what the King's Speech said about AI, what is happening elsewhere in the world, and what we can expect in the UK.

An emotional day - The Court of Appeal reverses the High Court’s earlier judgment

An emotional day - The Court of Appeal reverses the High Court’s earlier judgment

by Alex Burns

Today, the Court of Appeal handed down its hotly-anticipated judgment in the Emotional Perception AI case, the first case heard at this level on the patentability of AI-based inventions ...

Learn More

How AI is shaping the future of MedTech

Special Report

Led by Daniel Brodsky, this report looks into the challenges that arise while patenting MedTech innovations, in particular, uses for AI in the industry such as AI assisted devices and image analysis, the approaches taken by different national patent offices while protecting the MedTech sector and the increase in challenges that small applicants can face during this process compared to others.

This report highlights that the AI in MedTech space is a relatively young sector that is currently undergoing a period of rapid growth as new technologies continue to emerge.

Medtech wearble on wrist
Patent_Landscape_in_Bioinformatics_and_Digital_Health_Special_Report_2021-2-Compressed

Patent Landscape in Bioinformatics and Digital Health: a data-driven analysis

Special Report

The words "digital health", "data driven" and "AI" have been on everyone's lips and in many headlines in the healthcare and life sciences sectors over the last couple of years. However, navigating this rapidly changing landscape can be challenging for those in charge of managing the IP associated with the innovations underpinning these changes.  

In this Special Report, we set out to collect data on the patent landscape in the fields of bioinformatics and digital health, to see whether the growth we and our clients see in the field is reflected in the data and whether insights can be gained from the data that will assist in designing better, more informed IP strategies.

ME Forward Masthead White 2